home / stock / cocp / cocp short
Short Information | Cocrystal Pharma Inc. (NASDAQ:COCP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 209,994 |
Total Actual Volume | 1,052,301 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 1 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 10,500 |
Average Short Percentage | 21.17% |
Is there a COCP Short Squeeze or Breakout about to happen?
See the COCP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-17-2024 | $2.33 | $2.4061 | $2.51 | $2.31 | 13,497 | 407 | 3.02% |
06-14-2024 | $2.65 | $2.39 | $2.65 | $2.3 | 53,885 | 8,472 | 15.72% |
06-13-2024 | $2.76 | $2.6101 | $2.9893 | $2.53 | 64,350 | 15,523 | 24.12% |
06-12-2024 | $2.75 | $2.8 | $3.1 | $2.7 | 96,658 | 24,603 | 25.45% |
06-11-2024 | $2.47 | $2.72 | $2.72 | $2.47 | 24,308 | 5,161 | 21.23% |
06-10-2024 | $2.53 | $2.53 | $2.5981 | $2.45 | 20,126 | 5,014 | 24.91% |
06-07-2024 | $2.59 | $2.53 | $2.656 | $2.4517 | 36,084 | 4,443 | 12.31% |
06-06-2024 | $2.41 | $2.5801 | $2.74 | $2.4 | 140,240 | 29,567 | 21.08% |
06-05-2024 | $2.26 | $2.28 | $2.4202 | $2.26 | 27,024 | 2,405 | 8.9% |
06-04-2024 | $2.28 | $2.2992 | $2.3951 | $2.25 | 21,762 | 1,952 | 8.97% |
06-03-2024 | $2.25 | $2.32 | $2.3407 | $2.175 | 30,066 | 7,987 | 26.56% |
05-31-2024 | $2.29 | $2.25 | $2.3371 | $2.23 | 5,557 | 1,782 | 32.07% |
05-30-2024 | $2.15 | $2.36 | $2.45 | $2.15 | 74,781 | 10,325 | 13.81% |
05-29-2024 | $2.24 | $2.24 | $2.3299 | $2.1201 | 25,578 | 7,145 | 27.93% |
05-28-2024 | $2.25 | $2.25 | $2.33 | $2.12 | 108,931 | 15,307 | 14.05% |
05-24-2024 | $2.1 | $2.2 | $2.35 | $1.89 | 147,785 | 34,015 | 23.02% |
05-23-2024 | $2.09 | $2.07 | $2.2445 | $1.81 | 36,946 | 8,983 | 24.31% |
05-22-2024 | $1.891 | $2.1299 | $2.15 | $1.7654 | 101,742 | 16,250 | 15.97% |
05-21-2024 | $1.91 | $1.9 | $1.91 | $1.895 | 13,668 | 10,062 | 73.62% |
05-20-2024 | $1.8901 | $1.9 | $1.93 | $1.842 | 9,313 | 591 | 6.35% |
News, Short Squeeze, Breakout and More Instantly...
Cocrystal Pharma Inc. Company Name:
COCP Stock Symbol:
NASDAQ Market:
Cocrystal Pharma Inc. Website:
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed in Phase 2a influenza A human challenge study of oral CC-42344, with topline results expected ...
BOTHELL, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized, double-blind, placebo-controlled Phase 2a human...
FDA feedback following the Company’s submission of a Pre-IND briefing package improves clarity on regulatory requirements for Phase 2b influenza A clinical trial with oral CC-42344, a broad-spectrum PB2 inhibitor Topline data expected in 2024 from Phase 2a influenza A human challen...